Table 4.

Baseline characteristics for patients with first-line therapy in the treatment cohort (n=34)

Characteristics	Value
Age at nephrectomy (years)
Mean±SD	58.2±11.4
Median	58
Range	25–77
Gender
Male	23 (67.6%)
Female	11 (32.4)
Primary tumor status (pathologic TNM stage)*
I	7 (20.6%)
II	0
III	12 (35.3%)
IV	15 (44.1%)
Progression-free survival (months)
Mean±SD	18.7±19.0
Median	10.3
Range	1–65

*According to 2010 American Joint Committee on Cancer TNM staging.